Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2012-07-19

FDA Approved: BICALUTAMIDE — Supplemental Application (Viona Pharmaceuticals Inc.)

View source ↗

Summary

The FDA granted a supplemental approval for bicalutamide from Viona Pharmaceuticals, indicating an update to the approved product (labeling/administration detai…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • bicalutamide (bicalutamide)

Snippet

SUPPL AP for BICALUTAMIDE (BICALUTAMIDE)